Zollinger- Ellison syndrome associated with neurofibromatosis type I: a case report

被引:14
作者
Lee, WS
Koh, YS
Kim, JC
Park, CH
Joo, YE
Kim, HS
Cho, CK
Choi, SK
Rew, JS
Kim, SJ
机构
[1] Chonnam Natl Univ, Sch Med, Dept Internal Med, Div Gastroenterol, Donggu, Gwangju, South Korea
[2] Chonnam Natl Univ, Sch Med, Dept Surg, Donggu, Gwangju, South Korea
关键词
D O I
10.1186/1471-2407-5-85
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Neurofibromatosis type 1 is an autosomal dominant neurocutaneous disorder with characteristic features of skin and central nervous system involvement. Gastrointestinal involvement is rare, but the risk of malignancy development is considerable. Zollinger-Ellison syndrome is caused by gastrin-secreting tumors called gastrinomas. Correct diagnosis is often difficult, and curative treatment can only be achieved surgically. Case presentation: A 41-year-old female affected by neurofibromatosis type 1 presented with a history of recurrent epigastric soreness, diarrhea, and relapsing chronic duodenal ulcer. Her serum fasting gastrin level was over 1000 pg/mL. An abdominal CT scan revealed a 3 x 2-cm, well-enhanced mass adjacent to the duodenal loop. She was not associated with multiple endocrine neoplasia type 1. Operative resection was performed and gastrinoma was diagnosed by immunohistochemical staining. The serum gastrin level decreased to 99.1 pg/mL after surgery, and symptoms and endoscopic findings completely resolved without recurrences. Conclusion: Gastrinoma is difficult to detect even in the general population, and hence symptoms such as recurrent idiopathic peptic ulcer and diarrhea in neurofibromatosis type 1 patients should be accounted for as possibly contributing to Zollinger-Ellison syndrome.
引用
收藏
页数:8
相关论文
共 30 条
[1]   GENE FOR VON RECKLINGHAUSEN NEUROFIBROMATOSIS IS IN THE PERICENTROMERIC REGION OF CHROMOSOME-17 [J].
BARKER, D ;
WRIGHT, E ;
NGUYEN, K ;
CANNON, L ;
FAIN, P ;
GOLDGAR, D ;
BISHOP, DT ;
CAREY, J ;
BATY, B ;
KIVLIN, J ;
WILLARD, H ;
WAYE, JS ;
GREIG, G ;
LEINWAND, L ;
NAKAMURA, Y ;
OCONNELL, P ;
LEPPERT, M ;
LALOUEL, JM ;
WHITE, R ;
SKOLNICK, M .
SCIENCE, 1987, 236 (4805) :1100-1102
[2]   Neurofibromatosis type 1: brain stem tumours [J].
Bilaniuk, LT ;
Molloy, PT ;
Zimmerman, RA ;
Phillips, PC ;
Vaughan, SN ;
Liu, GT ;
Sutton, LN ;
Needle, M .
NEURORADIOLOGY, 1997, 39 (09) :642-653
[3]  
Cappelli C, 2004, Minerva Endocrinol, V29, P19
[4]  
CHAGNON JP, 1985, GASTROEN CLIN BIOL, V9, P65
[5]   Ampullary adenocarcinoma in Neurofibromatosis Type 1. Case report and literature review [J].
Costi, R ;
Caruana, P ;
Sarli, L ;
Violi, V ;
Roncoroni, L ;
Bordi, C .
MODERN PATHOLOGY, 2001, 14 (11) :1169-1174
[6]   ASSESSMENT AND PREDICTION OF LONG-TERM CURE IN PATIENTS WITH THE ZOLLINGER-ELLISON SYNDROME - THE BEST APPROACH [J].
FISHBEYN, VA ;
NORTON, JA ;
BENYA, RV ;
PISEGNA, JR ;
VENZON, DJ ;
METZ, DC ;
JENSEN, RT .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (03) :199-206
[7]  
Friedman JM, 1999, AM J MED GENET, V89, P1
[8]  
FULLER CE, 1991, HISTOPATHOLOGY, V19, P1
[9]   NEUROFIBROMATOSIS AND INSULINOMA [J].
FUNG, JWK ;
LAM, KSL .
POSTGRADUATE MEDICAL JOURNAL, 1995, 71 (838) :485-486
[10]   IDENTIFICATION OF THE NEUROFIBROMATOSIS TYPE-1 GENE-PRODUCT [J].
GUTMANN, DH ;
WOOD, DL ;
COLLINS, FS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (21) :9658-9662